You just read:

SynAgile Corporation Announces Positive Phase 2a Results for Continuous, Noninvasive, Intraoral Levodopa-Carbidopa Administration to Treat Parkinson's Disease

News provided by

SynAgile Corporation

Oct 08, 2015, 07:23 ET